Here are the developments that marked the last week in healthcare, handpicked by Becker's editors. To receive curated articles like this in your inbox daily, sign up for the Hospital Review newsletter here.
- While some hospitals and health systems are reporting strong balance sheets, others see big financial headwinds in 2025, in part because of CMS rate changes.
- Three years after its launch, Mark Cuban Cost Plus Drug Co. now manufactures injectables in shortage, works with thousands of healthcare facilities and offers 2,000 discounted generics. He recently shared his 2025 plans with Becker's.
- The spending bill that averted a government shutdown includes increased payments for low-volume hospitals and Medicare-dependent hospitals. Physicians, meanwhile, slammed Congress for opting not to address a pay cut that will take effect in 2025.
- There's a better way to deal with prior authorizations. The 1 change you can make today: here.
- AdventHealth has decreased wait times and left-before-being-seen rates by implementing "vertical bays" in some of its emergency departments.
- Federal officials maintain that the nation's bird flu outbreak does not pose an immediate threat to public health. However, infectious disease experts say recent developments indicate the H5N1 virus's spread is widening — and with it, the risks it poses to humans.
- Compliance alone can't fend off cyberattacks. Get proactive strategies to protect patient data here.
- Steward Health Care filed two WARN notices in Pennsylvania for a total of 848 employees after it submitted a closure notice for Sharon Regional Hospital.
- The FDA declared the end of the two-year shortages of Eli Lilly's Mounjaro and Zepbound and reaffirmed its decision to halt the production of compounded versions of the drugs.
- A team at The Ohio State University Wexner Medical Center set an institutional record by transplanting 10 kidneys in two days using a 20-person chain.
- Up to 80% of clinical trials don't meet their deadlines — how AI can help: here.
